Healthcare - Medical - Devices - NYSE - US
$ 320.31
-8.54 %
$ 8.98 B
Market Cap
-11.83
P/E
Price Target
Average
24.88%
Revenue Forecast
Estimate
3.51%
EBIT
Estimate
28.16%
Net Income
Estimate
29.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bio-Rad Laboratories, Inc.
Wall Street analysts predict an average 1-year price target for BIO of $400 , with forecasts ranging from a low of $400 to a high of $400 .
BIO Lowest Price Target
Wall Street Target
400 USD
24.88%
BIO Average Price Target
Wall Street Target
400 USD
24.88%
BIO Highest Price Target
Wall Street Target
400 USD
24.88%
REVENUE FORECAST
Revenue Forecast Chart BIO
EBIT FORECAST
EBIT Forecast Chart BIO
NET INCOME FORECAST
Net Income Chart BIO